Liraglutide Reference
Educational, not medical advice reference for Liraglutide: GLP-1, Fat Loss; regulatory status, evidence posture, source review, and schedule not…
Plain English
- What it is
- Liraglutide is an FDA-approved prescription medicine, not an experimental or research-only compound. It is a GLP-1 receptor agonist, meaning it copies a natural gut hormone that helps lower blood sugar and curb appetite. It is sold under the brand names Saxenda (for weight management) and Victoza (for type 2 diabetes).
- What people use it for
- Saxenda is approved to help adults and some adolescents reduce excess body weight and keep it off, paired with a lower-calorie diet and more physical activity. Victoza is the version used to help control blood sugar in people with type 2 diabetes.
- What the science shows
- This is one of the more established, approved GLP-1 medicines, so it carries strong human evidence behind its approved uses. The most common side effects are gut-related, including nausea, diarrhea, constipation, and vomiting, which is the usual pattern for this class of drug.
- The catch
- Liraglutide carries the FDA's most serious safety alert, a boxed warning: it caused thyroid C-cell tumors in rats and mice, and it must not be used by people with a personal or family history of medullary thyroid cancer (MTC) or the genetic syndrome MEN 2. It is prescription-only and belongs under a prescriber's care, and getting amounts wrong is a real risk, so it is not a casual supplement.
Reference summary
Daily liraglutide tracking is label-reference content and should be separated from weekly GLP-1 reminder logic.
Regulatory and posture
- Categories
- GLP-1, Fat Loss
- Aliases
- Saxenda label reference, Victoza active ingredient
- Evidence posture
- human
- Regulatory status
- FDA-approved liraglutide label references exist for branded products; this entry uses Saxenda obesity-management label context.
- Content review status
- label verified
Selected public sources
Related tools
- GLP-1 conversion calculator - Convert a GLP-1 mg dose to U-100 units and ml.
- GLP-1 ramp planner - Preview a linear educational dose-step table.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- PK simulator overview - Public overview of the Pro pharmacokinetic simulator.
- GLP-1 taper planner overview - Public overview of the Pro GLP-1 taper planner.
- Plateau analyzer overview - Public overview of the Pro plateau-pattern analyzer.
For research and educational purposes only. Not medical advice.